Home › Funds › Pacer Advisors, Inc. › REGN

Pacer Advisors, Inc. position in REGN

REGENERON PHARMACEUTICALS · Health Care

Pacer Advisors, Inc. reported holding 369,451 shares of REGN (REGENERON PHARMACEUTICALS) in its Q2 2026 13F filing — a position valued at US$230.4M, representing 0.66% of its reported portfolio and ranking #43 among its reported holdings. Pacer Advisors, Inc. has disclosed REGN holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)369.45K sh
Reported value held$230.37M
Portfolio Weight0.66%
First reportedQ3 2023
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Pacer Advisors, Inc.'s REGN position evolved

Pacer Advisors, Inc. first disclosed a stake in REGN in Q3 2023 at 12,281 shares (US$10.1M). The position peaked in Q4 2025 at 397,666 shares, worth US$306.9M. Across 12 filings, Pacer Advisors, Inc. increased the stake 7 time(s), trimmed it 3 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 369,451 shares valued at US$230.4M — an increase of 10,818 shares quarter over quarter.. Notable position changes include a 2297% increase in Q1 2025 (shares fell 17% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 12.28K $10.11M New
Q4 2023 14.13K $12.41M Add
Q1 2024 15.03K $14.47M Add
Q2 2024 16.46K $17.30M Add
Q3 2024 19.54K $20.54M Add
Q4 2024 17.00K $12.11M Reduce
Q1 2025 407.37K $258.37M Add
Q2 2025 445.13K $233.70M Add
Q3 2025 445.32K $250.39M Hold
Q4 2025 397.67K $306.95M Reduce
Q1 2026 358.63K $277.09M Reduce
Q2 2026 369.45K $230.37M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About REGN and 13F data

REGN (REGENERON PHARMACEUTICALS) is a Health Care company. 31 other funds we track also report a position in REGN — the largest reported positions include Dodge & Cox (US$3.04B), DODGE & COX (US$3.04B), LOOMIS SAYLES & CO L P (US$1.16B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding REGN

All REGN fund holders →

FAQ

How long has Pacer Advisors, Inc. held REGN?

Pacer Advisors, Inc. has disclosed REGN holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is Pacer Advisors, Inc.'s current position in REGN?

As of Q2 2026, Pacer Advisors, Inc. holds 369.45K shares of REGN (REGENERON PHARMACEUTICALS), valued at $230.37M, representing 0.66% of its reported portfolio and ranking #43.

Has Pacer Advisors, Inc. been buying or selling REGN?

In the latest 13F filing (Q2 2026), Pacer Advisors, Inc. increased its position in REGN. The position peaked in Q4 2025 at 397.67K shares.

Which other funds hold REGN?

Other major institutional holders of REGN include Dodge & Cox, DODGE & COX, LOOMIS SAYLES & CO L P, among 31 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.